ESC 365 - Subcutaneous GP IIb/IIIa inhibition

ESC Professional Premium Access

Subcutaneous GP IIb/IIIa inhibition

Session: Novel antithrombotic therapies in cardiovascular disease: what’s on the horizon?

Topic: Antiplatelet Drugs

Speaker: Professor J. ten Berg (Nieuwegein, NL)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Professor Jurrien M ten Berg

St Antonius Hospital, Nieuwegein (Netherlands (The))

20 presentations

4 followers

4 more presentations in this session

Subcutaneous P2Y12 inhibition

Speaker: Professor R. Storey (Sheffield, GB)

Glycoprotein VI inhibition

Speaker: Associate Professor C. Christersson (Uppsala, SE)

FXIa inhibition

Speaker: Professor D. Gorog (London, GB)

Novel antithrombotic therapies in cardiovascular disease: what’s on the horizon? - discussion

Access the full session

Novel antithrombotic therapies in cardiovascular disease: what’s on the horizon?

Speakers: Professor J. ten Berg, Professor R. Storey, Associate Professor C. Christersson, Professor D. Gorog

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources